Dr. Dennis Hsu
Claim this profileUniversity of Pittsburgh Cancer Institute (UPCI)
Studies Colorectal Cancer
Studies Colon Cancer
5 reported clinical trials
10 drugs studied
Area of expertise
1Colorectal Cancer
Stage IV
Stage II
dMMR positive
2Colon Cancer
Stage IV
Stage II
dMMR positive
Affiliated Hospitals
Clinical Trials Dennis Hsu is currently running
ZEN003694 + Chemotherapy
for Colorectal Cancer
This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with the usual treatment with capecitabine in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) or cannot be removed by surgery (unresectable) and that it has progressed on previous standard treatment. ZEN003694 is an inhibitor of a family of proteins called the bromodomain and extra-terminal (BET). It may prevent the growth of tumor cells that over produce BET protein. Capecitabine is in a class of medications called antimetabolites. It is taken up by cancer cells and breaks down into fluorouracil, a substance that kills cancer cells. Giving ZEN003694 in combination with capecitabine may be safe in treating patients with metastatic or unresectable solid tumors.
Recruiting1 award Phase 122 criteria
Irinotecan + FOLFOX Chemotherapy
for Rectal Cancer
This trial is testing different treatments in patients with advanced rectal cancer to see which one is more effective at shrinking the tumor or stopping its growth, potentially avoiding surgery.
Recruiting1 award Phase 2
More about Dennis Hsu
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dennis Hsu has experience with
- Oxaliplatin
- Capecitabine
- Fluorouracil
- Leucovorin
- ZEN003694
- Leucovorin Calcium
Breakdown of trials Dennis Hsu has run
Colorectal Cancer
Colon Cancer
Thyroid Cancer
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dennis Hsu specialize in?
Dennis Hsu focuses on Colorectal Cancer and Colon Cancer. In particular, much of their work with Colorectal Cancer has involved Stage IV patients, or patients who are Stage II.
Is Dennis Hsu currently recruiting for clinical trials?
Yes, Dennis Hsu is currently recruiting for 2 clinical trials in Pittsburgh Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Dennis Hsu has studied deeply?
Yes, Dennis Hsu has studied treatments such as Oxaliplatin, Capecitabine, Fluorouracil.
What is the best way to schedule an appointment with Dennis Hsu?
Apply for one of the trials that Dennis Hsu is conducting.
What is the office address of Dennis Hsu?
The office of Dennis Hsu is located at: University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania 15232 United States. This is the address for their practice at the University of Pittsburgh Cancer Institute (UPCI).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.